I
Iqbal Ike K. Ahmed
Researcher at University of Toronto
Publications - 239
Citations - 7586
Iqbal Ike K. Ahmed is an academic researcher from University of Toronto. The author has contributed to research in topics: Glaucoma & Intraocular pressure. The author has an hindex of 42, co-authored 218 publications receiving 5627 citations. Previous affiliations of Iqbal Ike K. Ahmed include University of Surrey & Wellcome Trust.
Papers
More filters
Journal ArticleDOI
Micro-invasive glaucoma surgery: current perspectives and future directions.
Hady Saheb,Iqbal Ike K. Ahmed +1 more
TL;DR: MIGS procedures offer reduction in IOP, decrease in dependence on glaucoma medications and an excellent safety profile, which differs from the role of more invasive glAUcoma surgeries such as trabeculectomy or glau coma drainage devices.
Journal ArticleDOI
The Ahmed versus Baerveldt study: three-year treatment outcomes.
Panos G. Christakis,Jeffrey W. Kalenak,James C. Tsai,David Zurakowski,Jeffrey A. Kammer,Paul Harasymowycz,Juan J. Mura,Louis B. Cantor,Iqbal Ike K. Ahmed +8 more
TL;DR: Both implants were effective in reducing IOP and the need for glaucoma medications and the Baerveldt group had a lower failure rate and a lower IOP on fewer medications than the Ahmed group, but had a small risk of hypotony that was not seen in the Ahmed Group.
Journal ArticleDOI
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up
Steven J. Gedde,William J. Feuer,Wei Shi,Kin Sheng Lim,Keith Barton,Saurabh Goyal,Iqbal K. Ahmed,James D. Brandt,Steven J Gedde,Michael R. Banitt,Donald L. Budenz,Richard K. Lee,Paul F. Palmberg,Richard K. Parrish,Luis E Vazquez,Sarah R. Wellik,Mark Werner,Jeffrey M. Zink,Anup K. Khatana,Davinder S. Grover,Arvind Neelakantan,Ahmed El Karmouty,Renata Puertas,Joseph F. Panarelli,Kateki Vinod,John Lind,Steven R. Shields,Pouya Alaghband,Mark B. Sherwood,Mahmoud A. Khaimi,Prithvi S. Sankar,Husam Ansari,Eydie Miller-Ellis,Robert M. Feldman,Laura A. Baker,Nicholas P. Bell,Iqbal Ike K. Ahmed,Donna Williams,Bruce E. Prum,Pradeep Y. Ramulu,Henry D. Jampel,W. Feuer,Luz Londono,Joyce C. Schiffman,Yolanda Silva,Elizabeth A. Vanner,Philip P. Chen,Dale K. Heuer,Kuldev Singh,Martha M. Wright +49 more
TL;DR: Lower IOP with use of fewer glaucoma medications was achieved after trabeculectomy with MMC compared with tube shunt surgery during the first year of follow-up.
Journal ArticleDOI
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Matthew B. Schlenker,Husayn Gulamhusein,Ina Conrad-Hengerer,Alix Somers,Markus Lenzhofer,Ingeborg Stalmans,Herbert A. Reitsamer,Fritz H. Hengerer,Iqbal Ike K. Ahmed +8 more
TL;DR: There was no detectable difference in risk of failure and safety profiles between standalone ab interno microstent with M MC and trabeculectomy with MMC.
Journal ArticleDOI
Original articleThe Ahmed Versus Baerveldt Study: One-Year Treatment Outcomes
Panos G. Christakis,Jeffrey W. Kalenak,David Zurakowski,James C. Tsai,Jeffrey A. Kammer,Paul Harasymowycz,Iqbal Ike K. Ahmed +6 more
TL;DR: The Ahmed Versus Baerveldt (AVB) study as discussed by the authors reported the 1-year treatment outcomes of the AVB study, where patients with uncontrolled glaucoma refractory to medicinal, laser, and surgical therapy were randomized to undergo implantation of an Ahmed-FP7 valve (New World Medical, Inc., Rancho Cucamonga, CA) or a Baervesldt-350 implant (Abbott Medical Optics, Inc, Santa Ana, CA), to be followed for 5 years.